Thomas Olin
Director Técnico/Científico/I+D en KANCERA AB .
Perfil
Thomas Olin is currently the Chief Executive Officer at iNovacia AB since 2006.
He is also a Director at Blasieholmen Investment Group AB.
In addition, he holds the position of Chief Scientific Officer & Executive VP at Kancera AB since 2010.
Previously, he served as the Chief Executive Officer & Director at SaltX Technology Holding AB.
He also worked as an Independent Director at Klaria Pharma Holding AB.
Prior to that, he was a Project Leader & Senior Researcher at Pharmacia & Upjohn, Inc. and an Area Manager-Nutrition Research at Pharmacia Hospital Care.
Cargos activos de Thomas Olin
| Empresas | Cargo | Inicio |
|---|---|---|
| KANCERA AB | Director Técnico/Científico/I+D | 01/07/2023 |
iNovacia AB
 iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Director Ejecutivo | 01/01/2006 |
| Blasieholmen Investment Group AB | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Thomas Olin.
| Empresas | Cargo | Fin |
|---|---|---|
| KLARIA PHARMA HOLDING AB | Director/Miembro de la Junta | - |
| Pharmacia Hospital Care | Corporate Officer/Principal | - |
| SALTX TECHNOLOGY HOLDING AB | Director Ejecutivo | - |
| Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| KANCERA AB | Health Technology |
| SALTX TECHNOLOGY HOLDING AB | Electronic Technology |
| KLARIA PHARMA HOLDING AB | Health Technology |
| Empresas privadas | 4 |
|---|---|
| Pharmacia & Upjohn, Inc. | Health Technology |
| Pharmacia Hospital Care | |
iNovacia AB
iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Commercial Services |
| Blasieholmen Investment Group AB |
- Bolsa de valores
- Insiders
- Thomas Olin
